AAL
62
-3
MO
48
12
AA
61
-2
JWN
53
-4
CAG
36
-10
NWSA
58
4
K
62
2
MRO
42
-5
GILD
54
3
GE
81
2
DE
56
3
DRI
58
-2
FFIV
67
-3
FOX
42
2
NVDA
59
-2
OXY
40
4
MMM
52
-5
MAC
64
2
ADT
43
-3
AMG
36
-2
AAL
62
-3
MO
48
12
AA
61
-2
JWN
53
-4
CAG
36
-10
NWSA
58
4
K
62
2
MRO
42
-5
GILD
54
3
GE
81
2
DE
56
3
DRI
58
-2
FFIV
67
-3
FOX
42
2
NVDA
59
-2
OXY
40
4
MMM
52
-5
MAC
64
2
ADT
43
-3
AMG
36
-2
Financhill
Back

thyssenkrupp AG Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
34

TKAMY
thyssenkrupp AG

Last Price:
3.86
Seasonality Move:
-2.82%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Sell
34
thyssenkrupp AG (TKAMY) is a Sell

Is thyssenkrupp AG a Buy, Sell or Hold?

  • The current thyssenkrupp AG [TKAMY] share price is $3.86. The Score for TKAMY is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • TKAMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TKAMY Stock Price Chart

What is thyssenkrupp AG's stock price today?

  • The thyssenkrupp AG share price today is $3.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TKAMY is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

TKAMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 64.67 Buy
Chaikin Money Flow: 3175 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.28 - 3.68) Buy
Bollinger Bands (100): (3.55 - 4.85) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

TKAMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.61 Buy
20-day SMA: 3.45 Buy
50-day SMA: 3.64 Buy
200-day SMA: 4.98 Sell
8-day EMA: 3.64 Buy
20-day EMA: 3.54 Buy
50-day EMA: 3.71 Buy
200-day EMA: 4.84 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

thyssenkrupp AG Earnings Growth & TKAMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

thyssenkrupp AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):